Argenx ARGX · NASDAQ
$819.14 -3.21% (-$27.13)
Summary
70 / 100 · Bulios Score
What speaks for it
- Out of every 100 USD of revenue, 31 USD is left as net profit.
- Revenue grew by 116% a year over the last 3 years.
- It holds more cash than debt: $3.58B against $47.0M.
- The share price is below the Bulios Fair Price.
What to watch
- Earnings per share swing sharply from year to year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 41.2 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 152% a year over 5 years. Over the last 3 years it grew by 116% a year. For the next fiscal year analysts expect revenue to grow by 49%.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
YesIt holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 32
- Hold 4
- Sell 0
Today's price within the analysts' price targets
The average target of $1,143 is 39% above today's price. 89% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
The company reports no revenue by product.
By region
- UNITED STATES 85%
- Rest Of The World 8.3%
- JAPAN 5.0%
- CHINA 1.6%
UNITED STATES brings in 85% of revenue.
Segments in detail